---
schema_version: "secwatch.filing_event.v1"
accession: "0000899923-25-000066"
form_type: "8-K"
ticker: "MYGN"
cik: "0000899923"
company_name: "MYRIAD GENETICS INC"
filed_at: "2025-06-05T23:59:59+00:00"
generated_at: "2026-05-19T23:22:31.855856+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Myriad shareholders approve 6.5M share increase to 2017 equity plan; per-participant cap raised

## Summary
- Stockholders approved amendment to 2017 Plan adding 6.5 million shares for equity grants.
- Board increased annual per-participant share cap from 500,000 to 574,040 shares.
- All three director nominees (Raha, Dreismann, Reitan) elected with >97% of votes cast.
- Advisory say-on-pay approved with 92% of votes cast in favor.
- Ernst & Young ratified as auditor for fiscal 2025 with 95.6% support.

## SEC filing metadata
- accession: 0000899923-25-000066
- form_type: 8-K
- ticker: MYGN
- cik: 0000899923
- company_name: MYRIAD GENETICS INC
- filed_at: 2025-06-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/899923/000089992325000066/0000899923-25-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/899923/000089992325000066/mygn-20250605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000899923-25-000066
- JSON: https://secwatch.observer/filing/0000899923-25-000066.json
- Plain text: https://secwatch.observer/filing/0000899923-25-000066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.